Pictet Asset Management (UK)’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-291,120
Closed -$3.7M 920
2018
Q1
$3.7M Sell
291,120
-1,674,351
-85% -$24.2M 0.01% 714
2017
Q4
$22.5M Buy
1,965,471
+314,931
+19% +$3.52M 0.06% 366
2017
Q3
$20.2M Buy
1,650,540
+1,014,290
+159% +$10.6M 0.06% 362
2017
Q2
$9.8M Buy
636,250
+24,544
+4% +$454K 0.03% 481
2017
Q1
$12.7M Buy
611,706
+251,249
+70% +$5.56M 0.04% 435
2016
Q4
$7.5M Buy
360,457
+167,821
+87% +$4.36M 0.03% 504
2016
Q3
$6.31M Sell
192,636
-240,418
-56% -$7.32M 0.02% 533
2016
Q2
$13M Buy
433,054
+353,254
+443% +$9.56M 0.05% 377
2016
Q1
$1.51M Buy
79,800
+19,400
+32% +$449K 0.01% 724
2015
Q4
$2M Buy
60,400
+14,000
+30% +$473K 0.01% 724
2015
Q3
$1.52M Buy
46,400
+2,300
+5% +$97.8K 0.01% 746
2015
Q2
$2.05M Sell
44,100
-18,600
-30% -$676K 0.01% 745
2015
Q1
$1.6M Buy
+62,700
New +$1.72M 0.01% 769

Other funds holding ALDR